Singapore markets open in 1 hour 51 minutes
  • Straits Times Index

    3,271.57
    +23.81 (+0.73%)
     
  • S&P 500

    4,349.93
    -6.52 (-0.15%)
     
  • Dow

    34,168.09
    -129.64 (-0.38%)
     
  • Nasdaq

    13,542.12
    +2.82 (+0.02%)
     
  • BTC-USD

    36,573.27
    -224.85 (-0.61%)
     
  • CMC Crypto 200

    835.69
    -20.12 (-2.35%)
     
  • FTSE 100

    7,469.78
    +98.32 (+1.33%)
     
  • Gold

    1,818.80
    -10.90 (-0.60%)
     
  • Crude Oil

    87.15
    +1.55 (+1.81%)
     
  • 10-Yr Bond

    1.8480
    +0.0650 (+3.65%)
     
  • Nikkei

    27,011.33
    -119.97 (-0.44%)
     
  • Hang Seng

    24,289.90
    +46.30 (+0.19%)
     
  • FTSE Bursa Malaysia

    1,515.76
    +6.85 (+0.45%)
     
  • Jakarta Composite Index

    6,600.82
    +32.65 (+0.50%)
     
  • PSE Index

    7,253.61
    -34.60 (-0.47%)
     

Roche not yet meeting demand for molecular COVID-19 tests - chairman

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
Logo of Swiss drugmaker Roche is seen in Basel
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • ROG.SW

VIENNA (Reuters) - Swiss drugmaker Roche is unable to meet demand for molecular tests to identify active COVID-19 infections, its chairman told Swiss daily Tagesanzeiger.

"The demand exceeds our production," Christoph Franz was quoted as saying in Saturday's paper. The decision on where tests were shipped to depended, among other things, on infection rates and the availability of diagnostic equipment.

Demand for its antibody tests, which determine whether people have ever been infected with the coronavirus, can be met as Roche has been boosting production, he said.

The drugmaker has said that it aims to more than double production of antibody tests to well over 100 million a month by the end of the year.

Franz said that Roche had started research on a potential drug to treat COVID-19 but added that these efforts were at a very early stage.

(Reporting by Kirsti Knoll, editing by Louise Heavens)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting